U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780539) titled 'Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors' on Aug. 19.
Brief Summary: Prior clinical trials have demonstrated promising efficacy and manageable safety of surufatinib in neuroendocrine tumors (NETs). This real-world study aims to evaluate the clinical efficacy and safety of surufatinib in patients with NETs, providing additional real-world evidence to support clinical application, guide novel therapeutic strategies, and ultimately improve patient outcomes.
Study Start Date: Sept. 01
Study Type: OBSERVATIONAL
Condition:
Neuroendocrine (NE) Tumors
Intervention:
DRUG: Suru...